New Delhi:
Ahead of the COVID-19 vaccination drive that begins Saturday, Union Health Minister Harsh Vardhan took to Twitter on Thursday, to dispel doubts about the vaccines.
Posting a series of graphics on Twitter, the minister addressed fears like the vaccine causing infertility or spreading the coronavirus infection.
“There is no scientific evidence to suggest that #COVIDVaccine could cause infertility in either men or women. Kindly do not pay heed to such rumours or information from unverified sources,” he mentioned in a single tweet.
“You cannot contract #COVID19 because you have been inoculated with a #COVID19Vaccine Temporary side effects such as mild fever should not be confused as having contracted #COVID,” the minister mentioned in one more.
After becoming administered #COVID19Vaccine, some men and women might have side effects like mild fever, discomfort at injection web site & bodyache. This is comparable to the side effects that take place post some other vaccines.
These are anticipated to go away on their personal just after some time. #StaySafepic.twitter.com/VCnJzXu70S
— Dr Harsh Vardhan (@drharshvardhan) January 14, 2021
You can not contract #COVID19 simply because you have been inoculated with a #COVID19Vaccine
Temporary side effects such as mild fever must not be confused as getting contracted #COVID.#StayInformedStaySafe@PMOIndia@MoHFW_INDIApic.twitter.com/ZkZgLU8tpy
— Dr Harsh Vardhan (@drharshvardhan) January 14, 2021
There is no scientific proof to recommend that #COVIDVaccine could lead to infertility in either guys or ladies. Kindly do not spend heed to such rumours or details from unverified sources.#StayInformedStaySafe@PMOIndia@MoHFW_INDIApic.twitter.com/6ii2EFgpB0
— Dr Harsh Vardhan (@drharshvardhan) January 14, 2021
The government on Saturday will launch what it says is the world’s largest vaccination programme with shots manufactured in India – a single created by Oxford University and pharma giant AstraZeneca, the other by Bharat Biotech International and India’s major clinical study body.
Authorities will treat the domestic COVID-19 vaccine “equally” with the prominent international a single, even even though the homegrown drug’s efficacy has not been verified, and men and women will have no option which they a single they get, government officers have hinted.
Administering Bharat Biotech’s Covaxin, a move cheered by politicians has worried some wellness professionals who take into consideration it rushed, as the vaccine has only restricted, “clinical-trial mode” approval and has not completed Phase 3 trials when its efficacy is measured.
Experts at India’s drug regulator this month advisable stricter monitoring for Covaxin, as is completed throughout clinical trials, in particular if situations of infection by mutant strains of the virus spread quick. At the similar time, the government desires to inoculate as several men and women as feasible as demand for vaccines outstrips provide.
Health advocacy groups, watchdogs and opposition politicians have questioned the vaccine’s approval, which came just a day just after the authorities asked Hyderabad-primarily based Bharat Biotech for more proof it would work.
(With inputs from agencies)